The Economic Times Healthcare and Biotech NewsThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the latest items in this publication.

571 records returned

Ranbaxy recalls over 4,000 cartons of acne drug in USEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Ranbaxy Laboratories has initiated a voluntary recall of 4,348 cartons of its best-selling drug Sotret (isotretinoin, 40 mg) used to treat acne in the US, as they are a part of one batch of tablets which were found to be ‘out of specification’. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 20, 2009 Category: Pharmaceuticals Source Type: news

Indian pharmaceutical market is over Rs 55,000 crEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Indian pharmaceutical market, which has registered robust growth in last few years, was valued at over Rs 55,000 crore in the last fiscal, the Lok Sabha was informed today. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 19, 2009 Category: Pharmaceuticals Source Type: news

Sun Pharma subsi gets USFDA nod for anti-hypertension drugEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Drug firm Sun Pharmaceutical Industries on Wednesday said that its subsidiary, has received US Drug regulator approval for anti-hypertension drug. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 18, 2009 Category: Pharmaceuticals Source Type: news

Sun Pharma gets US nod for leukaemia drugEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
It has secured tentative approval from the united states food and drugs administration for the generic version of gleeven (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 17, 2009 Category: Pharmaceuticals Source Type: news

Rs 10 crore sops for 8 more AIIMSEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In order to expedite the construction of eight new AIIMS-like institutes in the country, Union health minister Ghulam Nabi Azad announced incentives of up to Rs 10 crore for early completion of these projects. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 17, 2009 Category: Pharmaceuticals Source Type: news

Medicis deal, generic biz to boost financialsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Recent developments could well be a pointer to better days ahead for Glenmark Pharma which has had a relatively poor performance in the past four quarters. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 16, 2009 Category: Pharmaceuticals Source Type: news

Now, Zydus moves court against SunEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The battle-lines have been drawn between Mumbai-based Sun Pharmaceutical and its Ahmedabad-based rival Zydus Cadila. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 16, 2009 Category: Pharmaceuticals Source Type: news

Glenmark Generics settles litigation with MedicisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Glenmark Generics Inc, the US unit of Glenmark Generics Ltd , on Monday said that it has settled all pending litigation with Medicis Pharmaceutical Corp relating to patent actions regarding Fluocinonide. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 16, 2009 Category: Pharmaceuticals Source Type: news

Indian medical devices cos finding space in global arenaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A bunch of mid-sized Indian companies have seized the opportunity in the global life-saving medical devices market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 12, 2009 Category: Pharmaceuticals Source Type: news

Ranbaxy gets WHO approval for AIDS drugEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Ranbaxy Laboratories , India's top drug maker by sales, said on Thursday that it has received the World Health Organization pre-qualification for its Indinavir anti-retroviral AIDS drug. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 12, 2009 Category: Pharmaceuticals Source Type: news

Aurobindo gets USFDA approval for hypertension treating drugEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Drug firm Aurobindo Pharma on Thursday said that it has received final approval from the US health regulator for Perindopril Erbumine Tablets, used for the treatment of hypertension. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 12, 2009 Category: Pharmaceuticals Source Type: news

Watch out for US recovery, new productsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Robust growth in profits despite modest rise in revenues characterised the performance of the Indian pharma sector for the latest quarter ended September 2009. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 12, 2009 Category: Pharmaceuticals Source Type: news

CLB to hear Ranbaxy plea on FridayEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The Company Law Board (CLB) will hear a complaint by Ranbaxy Laboratories, which is contesting the appointment of two independent directors on the board of Zenotech by the founder and MD of the Hyderabad-based firm Jayaram Chigurupati, on Friday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news

HC admits DBS’ plea against WockhardtEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The Bombay High Court has admitted an application filed by Singapore-based DBS against debt-ridden drug maker Wockhardt’s plans to divest some of its assets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news

Novartis puts R&D activities in India on holdEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
MUMBAI: Frustrated with patent challenges, Swiss-pharma giant Novartis has put its research and development (R&D) activities in India on the back burner, its CEO Daniel Vasella said. Mr Vasella, who was in town to attend the Pepsico board meet, said the intellectual property (IP) protection was not up to the mark in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news

Cipla to export anti-Swine flu drugs to USEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Pharma firm Cipla Ltd said it is looking to export Antiflu, the drug used in the treatment of influenza AH1N1 (swine flu) virus, to US markets. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news

India to WIPO chief: MNCs working against Indian drug firmsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
India on Wednesday complained to the UN intellectual property rights body, WIPO, that some multinational firms have launched campaign against country's pharmaceutical industry, which has broken their "cartel" in the generic drugs. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news

Tata Elxsi, NH in pact to develop healthcare solutionsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Tata Group company, Tata Elxsi has entered into an agreement with Bangalore-based Narayana Hrudayalaya to develop affordable healthcare solutions. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news

Cipla launches drug to treat H1N1 virusEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Drug maker Cipla Ltd on Wednesday launched its generic version of Roche's Tamiflu, used in the treatment of the H1N1 swine flu virus, the firm said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news

Dr Reddy's unit rev to grow 10-15 pc in FY10Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Dr Reddy's Laboratories expects revenue at its pharmaceutical ingredients and outsourcing services unit to rise 10-15 per cent in this fiscal year, helped by stability in global economy, an official said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news

Nano draws biotech giant Alexandria to GujaratEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
US firm plans Rs 500 crore unit next to Tata Motors’ project. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news

Daiichi to leverage Ranbaxy abroadEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Japan’s Daiichi Sankyo, which controls Ranbaxy Laboratories, will use the Indian company as a launch pad to sell its patented drugs in Europe, China and the US and will work together in developing new products, a senior company official said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news

Indian generic firms to gain from Obama’s healthcare billEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The Indian generic companies expect to gain from the Obama government’s new healthcare bill which could lead to increased consumption of generic drugs. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 9, 2009 Category: Pharmaceuticals Source Type: news

Govt plans new norms for ads on emergency contraceptive pillsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The government has decided to frame guidelines on advertisements of emergency contraceptive pills (ECP) to ensure consumers be aware of the side-effects of the product. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 9, 2009 Category: Pharmaceuticals Source Type: news

US health bill to benefit local generic firmsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The US healthcare bill, which has been passed by the US House of Representatives and is awaiting nod from the Senate, holds a lot of promise for generic drug manufacturers from India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 9, 2009 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets US FDA nod for Cefotaxime injectionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Aurobindo Pharma today said it has got the final approval from the US drug regulator to market its antibiotic Cefotaxime injection used for treating various infections. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 9, 2009 Category: Pharmaceuticals Source Type: news

Daiichi Sankyo to launch Ranbaxy's drugs in Japan soonEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Daiichi Sankyo is going to launch some of Ranbaxy's generic medicine in the Japanese market soon. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 9, 2009 Category: Pharmaceuticals Source Type: news

Issues with USFDA to take long to resolve: RanbaxyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Ranbaxy is in talks with the US Food and Drug Administration (USFDA)to sort out issues related to generic drugs but the matter is likely to take long to resolve. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 9, 2009 Category: Pharmaceuticals Source Type: news

Zydus first Indian co to file H1N1 clinical trialsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The race among Indian pharma companies engaged in swine flu vaccine development may soon throw up a winner just when the pandemic enters a critical stage with the onset of winter. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 9, 2009 Category: Pharmaceuticals Source Type: news

Jubilant to exit non-core biz by MarEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Pharma company Jubilant Organosys expects to complete the divestment of its non-core business by the end of this fiscal and is also expanding its US operations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 8, 2009 Category: Pharmaceuticals Source Type: news

Dr Reddy's files for marketing Lipitor genericEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Dr Reddy's Laboratories has filed for marketing a generic version of Pfizer's cholesterol-lowering drug Lipitor in the US. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 7, 2009 Category: Pharmaceuticals Source Type: news

India, EU to resolve generic drugs exports tangleEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The European Union (EU) is not opposed to exports of generic medicine by Indian companies through its ports, European Commissioner for Trade Catherine Ashton said here Friday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 6, 2009 Category: Pharmaceuticals Source Type: news

Daiichi Sankyo begins late-stage trials of flu drugEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Daiichi Sankyo, has begun a late-stage trial in Japan for the influenza treatment laninamivir, a drug that aims to prevent new H1N1 flu. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 5, 2009 Category: Pharmaceuticals Source Type: news

Lab to enterprise solutionsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The Union Department of Science and Technology (DST) has embarked on several projects that are meant to go beyond social relevance. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 3, 2009 Category: Pharmaceuticals Source Type: news

Matsyafed sniffs new biz in nutraceutical domainEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Matsyafed has been engaged in the implementation of a broad range of welfare schemes for the fishing community, with the objective of ensuring their socio-economic uplift. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 3, 2009 Category: Pharmaceuticals Source Type: news